ARTIA GLOBAL PARTNERS LP
Adviser information for ARTIA GLOBAL PARTNERS LP last updated from Form ADV on March 26th, 2024. Select data displayed; additional Form ADV, Form D, Form 13F and other data is available from the Fincoded API.
Advisory Business
Type of Organization | Limited Partnership |
---|---|
Fiscal Year End | DECEMBER |
Legal Location | Delaware, United States |
Employees
Total Number of Employees | 3 |
---|---|
Investment Advisory/Research | 2 |
Registered Broker-Dealer Representatives | 0 |
Registered State Investment Advisers | 0 |
Licensed Agents of an Insurance Company | 0 |
No. of Firms/People that Solicit Clients | 0 |
RAUM
Provides Management of Securities Portfolios | Yes |
---|
Type | Accounts | RAUM |
---|---|---|
Discretionary | 3 | $428.2M |
Non-Discretionary | 0 | $0 |
Total | 3 | $428.2M |
Clients
Type | Number | RAUM |
---|---|---|
Individuals | 0 | $0 |
HNW Individuals | 0 | $0 |
Banking or thrift institutions | 0 | $0 |
Investment companies | 0 | $0 |
Business development companies | 0 | $0 |
Pooled investment vehicles | 3 | $428.2M |
Pension and profit sharing plans | 0 | $0 |
Charitable organizations | 0 | $0 |
State or municipal gov entities | 0 | $0 |
Other investment advisers | 0 | $0 |
Insurance companies | 0 | $0 |
Sovereign wealth funds and foreign official institutions | 0 | $0 |
Corporations or other businesses | 0 | $0 |
Other | 0 | $0 |
Type | Number |
---|---|
No. of Non-RAUM Clients | 0 |
No. of Non-U.S. Clients | 66 |
Services
Advisory Services | Portfolio management for pooled investment vehicles |
---|---|
Compensation | % of AUMPerformance-based fees |
Principal Office
1395 BRICKELL AVENUESTE 800
MIAMI
FL
United States
Monday - Friday, 9:00AM - 5:00PM
Tel: 305-710-1384, Fax: None
Chief Compliance Officer
WILLIAM VERDI
CHIEF FINANCIAL OFFICER
1395 BRICKELL AVENUE
STE 800
MIAMI
FL
United States
Tel:
305-260-1046
W*****@**************M
(Full email address available in API data)
Industry Affiliates
ARTIA GLOBAL ALPHA FUND GP LLC | Commodity pool operator or commodity trading advisorSponsor, GP, manager of pooled investment vehicles |
Private Funds
Name | Type | Assets $USD | Min Investment $USD | No. Owners |
---|---|---|---|---|
ARTIA GLOBAL ALPHA MASTER FUND LP | Hedge Fund | $428.2M | $30.0M | 6 |
Control Persons
Name | Type | Entity | Title | Since | Ownership |
---|---|---|---|---|---|
CHANTANAPONGWANIJ, ONUSA, NMN | Individual | – | MANAGING PARTNER | 04/2022 | > 75% |
ARTIA GLOBAL PARTNERS GP LLC | Domestic Entity | – | GENERAL PARTNER | 04/2022 | < 5% |
CHANTANAPONGWANIJ, ONUSA, NMN | Individual | ARTIA GLOBAL PARTNERS GP LLC | MANAGING MEMBER | 04/2022 | > 75% |
VERDI, WILLIAM, CHRISTOPHER | Individual | – | CHIEF COMPLIANCE OFFICER AND CHIEF FINANCIAL OFFICER | 09/2023 | < 5% |
No. Employees, Historic
RAUM, Historic
No. Clients, Historic
Holdings
From latest 13F, filed August 14th, 2024 for period ending June 30th, 2024
Name | Class | Value $USD | # Shares | Private Fund |
---|---|---|---|---|
ALNYLAM PHARMACEUTICALS INC | COM | 9M | 35K | NONE |
ANNEXON INC | COM | 723K | 147K | NONE |
APOGEE THERAPEUTICS INC | COM | 2M | 58K | NONE |
ARGENX SE | SPONSORED ADR | 7M | 15K | NONE |
ASCENDIS PHARMA A/S | SPONSORED ADR | 1M | 7K | NONE |
ASTRAZENECA PLC | SPONSORED ADR | 15M | 191K | NONE |
AXSOME THERAPEUTICS INC | COM | 7M | 88K | NONE |
CELLDEX THERAPEUTICS INC NEW | COM NEW | 3M | 75K | NONE |
CHARLES RIV LABS INTL INC | COM | 1M | 7K | NONE |
CORBUS PHARMACEUTICALS HLDGS | COM NEW | 905K | 20K | NONE |
CRINETICS PHARMACEUTICALS IN | COM | 4M | 86K | NONE |
DISC MEDICINE INC | COM | 606K | 13K | NONE |
DYNE THERAPEUTICS INC | COM | 4M | 119K | NONE |
ELI LILLY & CO | COM | 84M | 93K | NONE |
ELI LILLY & CO | COM | 68M | 75K | NONE |
EYEPOINT PHARMACEUTICALS INC | COM NEW | 883K | 102K | NONE |
IDEAYA BIOSCIENCES INC | COM | 2M | 54K | NONE |
INSMED INC | COM PAR $.01 | 4M | 53K | NONE |
INSMED INC | COM PAR $.01 | 7M | 110K | NONE |
INTRA-CELLULAR THERAPIES INC | COM | 15M | 217K | NONE |
IONIS PHARMACEUTICALS INC | COM | 3M | 62K | NONE |
KEROS THERAPEUTICS INC | COM | 914K | 20K | NONE |
KURA ONCOLOGY INC | COM | 1M | 57K | NONE |
LARIMAR THERAPEUTICS INC | COM | 656K | 90K | NONE |
MADRIGAL PHARMACEUTICALS INC | COM | 436K | 2K | NONE |
MERCK & CO INC | COM | 55M | 443K | NONE |
MEREO BIOPHARMA GROUP PLC | SPON ADS | 2M | 421K | NONE |
MERUS N V | COM | 3M | 50K | NONE |
NEUROCRINE BIOSCIENCES INC | COM | 6M | 45K | NONE |
NEWAMSTERDAM PHARMA COMPANY | ORDINARY SHARES | 1M | 54K | NONE |
NOVO-NORDISK A S | ADR | 99M | 692K | NONE |
NOVO-NORDISK A S | ADR | 44M | 310K | NONE |
OCULAR THERAPEUTIX INC | COM | 3M | 500K | NONE |
PLIANT THERAPEUTICS INC | COM | 538K | 50K | NONE |
PROTAGONIST THERAPEUTICS INC | COM | 4M | 124K | NONE |
SAREPTA THERAPEUTICS INC | COM | 411K | 3K | NONE |
SILENCE THERAPEUTICS PLC | ADS | 997K | 52K | NONE |
SOLENO THERAPEUTICS INC | COM | 4M | 94K | NONE |
SPRINGWORKS THERAPEUTICS INC | COM | 2M | 54K | NONE |
SYNDAX PHARMACEUTICALS INC | COM | 991K | 48K | NONE |
VAXCYTE INC | COM | 6M | 76K | NONE |
VERONA PHARMA PLC | SPONSORED ADS | 2M | 131K | NONE |
VERTEX PHARMACEUTICALS INC | COM | 9M | 19K | NONE |
VIKING THERAPEUTICS INC | COM | 24M | 453K | NONE |
VIKING THERAPEUTICS INC | COM | 8M | 150K | NONE |
XENON PHARMACEUTICALS INC | COM | 2M | 40K | NONE |